about
Assessing neurotoxicity from the low-dose radiation component of radiosurgery using magnetic resonance spectroscopy.Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy.How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems.Association between RT-induced changes in lung tissue density and global lung function.Does pneumonectomy have a role in the treatment of stage IIIA non-small cell lung cancer?Long-Term Outcomes of Lobectomy for Non-Small Cell Lung Cancer After Definitive Radiation TreatmentCardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study.Patterns of Failure After Surgery for Non-Small-cell Lung Cancer Invading the Chest Wall.Plasma Metabolites and Risk of Radiation-induced Esophagitis: A Secondary Analysis from a Prospective Study.Radiotherapy dose-response analysis for diffuse large B-cell lymphoma with a complete response to chemotherapySomnolence syndrome after focal radiation therapy to the pineal region: case report and review of the literature.Patterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumes.Timing of local and distant failure in resected lung cancer: implications for reported rates of local failure.Stereotactic body radiation therapy for treatment of primary and metastatic pulmonary malignancies.Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?Stereotactic body radiotherapy: a critical review for nonradiation oncologists.Radiation Therapy for Cutaneous T-Cell Lymphomas.Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity.Dosimetric advantages of intensity modulated radiation therapy in locally advanced lung cancer.Preoperative radiation therapy and chemotherapy for pulmonary blastoma: a case report.Standardized beam bouquets for lung IMRT planning.Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.Metastasis dynamics for non-small-cell lung cancer: effect of patient and tumor-related factors.Quantification and minimization of uncertainties of internal target volume for stereotactic body radiation therapy of lung cancer.Formation of a bronchoesophageal fistula following concurrent radiation and chemotherapy for lung cancer in the setting of Behçet's disease.Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer.Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: calculations from clinical trials.Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy.Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer.Factors associated with the development of brain metastases: analysis of 975 patients with early stage nonsmall cell lung cancer.Functional airway obstruction observed with hyperpolarized 129 Xenon-MRI.Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.Dosimetric effects of rotational offsets in stereotactic body radiation therapy (SBRT) for lung cancer.Diabetes mellitus: A significant co-morbidity in the setting of lung cancer?Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
P50
Q30477377-A895B98C-D980-4105-A8BE-2F7E6B1423BFQ30872793-DA903678-FB8F-4515-9E05-A7B2666863A2Q33988434-A73705C4-BF4E-47A9-B829-1FE438A2DC32Q34164979-90FA3459-2C6C-4046-8559-469D2FE4A707Q34870652-359BA439-C7DD-4E69-B9F2-9FCE6BD0AECFQ35039285-E2CD7F6C-F1EB-45AC-BB12-A81E806EAC0FQ35690398-62491BC1-3F9D-4974-BA33-A1C3DBC2A72FQ35892403-B5298C9C-79E6-421D-8497-551714DD007EQ36222717-4A58C026-A8DD-4995-B612-5865364D6165Q36274734-8EE2C008-F7CF-4F9E-A251-1490599BDE92Q36299343-F250C9CC-7A33-4C9B-8C87-4EB8783DFFAEQ36436788-725FB280-40C5-491F-B22C-7DBAA796680BQ36471950-7AD48E3C-1DE8-4784-AFF5-6BD8C6791B23Q37630320-6211B9CF-30E9-4BFC-B15B-EAB9113BABBBQ38102081-DFA1B046-3813-4E24-A496-E6DD3FC13585Q38122770-FA571164-71C3-4223-9F10-42F7719CA165Q38175120-34E30BCE-2C99-4C79-82EA-F13B4530E8BAQ38598530-5BE8B7B1-5B69-46FA-BB9A-CAD0A5C9DE88Q38735528-A6AD15CB-81A8-4ED3-BFFB-6E486EA710EDQ38849416-A432A8BA-3EB3-452D-BEB4-43A16F4C240DQ41039242-3FB48306-DC19-4DF5-B5C1-38680666DA62Q41039681-973D46E6-5A61-4E4F-A537-0596E7F976D7Q43184318-1475BE0F-B5F7-484C-837F-AA03214CED9BQ43215842-26DF42FB-AAA0-454D-AAD9-681DDA5E7775Q45010421-829BFD47-C76F-48D1-A55E-3780BB8A33FCQ45784076-CA5D402C-F0C8-461D-964F-AF2198D9A5C6Q46140329-7F39923F-3036-45B1-9525-33943BEE2C49Q46268837-0AD04119-F74F-414C-9F68-F2D4227E22EFQ46986578-3CA228FD-024E-43BC-8C7E-FA8464AF3BAEQ47287962-841D378A-9158-41CA-B9E4-110AF05039D9Q47359493-173A6D59-B559-412F-9B14-E9C053D6C843Q47907783-9EADFBA4-5139-4AA2-810B-F4243D81BB59Q48128817-8EBCCEF5-79A0-4726-A1C3-E621426ABA63Q48303565-BFB9C6B1-9BA1-40E1-8A3D-0C56B9245E7CQ48369218-5342B909-33EF-4E5E-98D2-714F4693B589Q48891867-581424A8-6F9B-45C6-AD17-4F9528F16AB3Q50050603-3E6B98A2-CE16-4848-89D5-4793B76E33D0Q50568311-A5F8E779-1ED8-4DE1-B87A-819F01AB26BFQ50943248-7F33C83B-663F-420F-AD25-60E1A1D4CDE1Q50950557-AA3D6FCC-B6DA-4B06-81CC-44D3DC9C8D66
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christopher R. Kelsey
@ast
Christopher R. Kelsey
@en
Christopher R. Kelsey
@es
Christopher R. Kelsey
@nl
Christopher R. Kelsey
@sl
type
label
Christopher R. Kelsey
@ast
Christopher R. Kelsey
@en
Christopher R. Kelsey
@es
Christopher R. Kelsey
@nl
Christopher R. Kelsey
@sl
prefLabel
Christopher R. Kelsey
@ast
Christopher R. Kelsey
@en
Christopher R. Kelsey
@es
Christopher R. Kelsey
@nl
Christopher R. Kelsey
@sl
P106
P1153
9942380500
P21
P31
P496
0000-0002-4961-8982